Skip to main content
Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc. — Investor Relations & Filings

Ticker · RLAY ISIN · US75943R1023 US Manufacturing
Filings indexed 484 across all filing types
Latest filing 2022-06-27 Regulatory Filings
Country US United States of America
Listing US RLAY

About Relay Therapeutics, Inc.

https://relaytx.com/

Relay Therapeutics, Inc. is a clinical-stage precision medicines company focused on transforming the drug discovery process. The company's approach is centered on understanding protein motion, utilizing its proprietary Dynamo® platform which integrates advanced computational and experimental methods. This platform enables the visualization of protein dynamics to design novel therapies for targets that have been historically considered intractable or 'undruggable'. Relay Therapeutics is advancing a pipeline of therapeutic candidates with an initial focus on precision oncology and genetic diseases.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The text includes a detailed disclosure about a regulatory and clinical data update for a drug candidate, a press release, and a virtual analyst and investor event presentation. It does not contain comprehensive financial statements or annual/quarterly financial results. The document is not an earnings release, annual report, or interim report. It is primarily a regulatory filing to disclose material events and updates to investors and the SEC. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and content support this classification with high confidence.
2022-06-27 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-27 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-27 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-27 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-27 English
FORM 4 SUBMISSION
Director's Dealing
2022-05-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.